Pharmaceuticalization: AIDS Treatment and Global Health Politics
Author:
- João Guilherme BiehlJBJoão Guilherme Biehl
- 1 September 2007
- journal article
- research article
- Published by Project MUSE in Anthropological Quarterly
- Vol. 80 (4) , 1083-1126
Abstract
This article examines the political economy of pharmaceuticals that lies behind global AIDS treatment initiatives, revealing the possibilities and inequalities that come with a magic bullet approach to health care. It tells how Brazil, against all odds, became the first developing country to universalize access to antiretroviral drugs—a breakthrough made possible by an unexpected alliance of activists, government reformers, development agencies, and the pharmaceutical industry. The article moves between a social analysis of the institutional practices shaping the Brazilian response to AIDS and the stories and lives of people affected by it. It draws from interviews with activists, policy makers, and corporate actors and from longitudinal ethnographic work among grassroots AIDS care services. Pharmaceutical innovations allow unlikely coalitions that both expose the inadequacies of reigning public health paradigms and act to reform, if to a limited extent, global values and mechanisms (of drug pricing and of types of medical and philanthropic interventions, for example). Treatment rollouts are matters of intense negotiation; their local realizations are shaped by contingency and uncertainty. Such realizations encode diverse economic and political interests, as well as the needs and desires of citizens. These therapeutic coalitions also expose the deficiencies of national and local infrastructures and consolidate novel state-civil society relations. A pharmaceutically-centered model of public health has emerged as a byproduct of AIDS treatment scale-up and the sustainability of the Brazilian AIDS policy has to be constantly renegotiated in light of global drug markets. A multitude of networks and variations in AIDS care have emerged on-the-ground, and the article explores why AIDS treatment has been so difficult to put into practice among poor Brazilians, who are often stigmatized as noncompliant or untreatable, becoming invisible to the public. Poor AIDS patients live in a state of flux, simultaneously acknowledging and disguising their condition while they participate in local economies of salvation. At both the macro and micro levels, we see a state of triage and a politics of survival crystallizing.Keywords
This publication has 21 references indexed in Scilit:
- Sovereignty RevisitedAnnual Review of Anthropology, 2006
- Will to Live: AIDS Drugs and Local Economies of SalvationPublic Culture, 2006
- How Do Intellectual Property Law and International Trade Agreements Affect Access to Antiretroviral Therapy?PLOS Medicine, 2006
- Building effective public–private partnerships: Experiences and lessons from the African Comprehensive HIV/AIDS Partnerships (ACHAP)Social Science & Medicine, 2006
- Globalization, Power and Survival: an Anthropological PerspectiveAnthropological Quarterly, 2006
- HUMAN RIGHTS AND GLOBAL HEALTH: A RESEARCH PROGRAMMetaphilosophy, 2005
- An adherence trilogy is essential for long-term HAART successThe Brazilian Journal of Infectious Diseases, 2003
- The Dilemma of Intellectual Property Rights for Pharmaceuticals: The Tension Between Ensuring Access of the Poor to Medicines and Committing to International AgreementsDeveloping World Bioethics, 2003
- Impact of Adherence to Antiretroviral Therapy in HIV-1–Infected Patients at a University Public Service in BrazilAIDS Patient Care and STDs, 2001
- Global Responses to AIDS: Science in EmergencyContemporary Sociology: A Journal of Reviews, 2001